Clinical Trial Update: The Study of p62/SQSTM1 as a Malignant Transformation Marker for Oral Potentially Malignant Disorders and a Prognostic Marker for Oral Squamous Cell Carcinoma

View source ↗

Summary

Clinical trial investigating p62/SQSTM1 as a biomarker for malignant transformation in oral potentially malignant disorders and as a prognostic marker for oral …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Potentially Malignant Disorder
• Oral Squamous Cell Carcinoma

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Oral Potentially Malignant Disorder, Oral Cancer | Status: UNKNOWN